Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | SSTR2 | P30874 | 4/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.32 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.30 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26529010 | 0.98 | MAP4K4 (0.35) | MAP4K4HTR7SSTR2NTRK1NTRK3 | |
| SCHEMBL26529605 | 0.94 | MAP4K4 (0.35) | MAP4K4HTR7SSTR2PGR | |
| SCHEMBL26528758 | 0.93 | HTR7 (0.36) | MAP4K4HTR7SSTR2NTRK1NTRK3 | |
| SCHEMBL26529628 | 0.92 | BRD9 (0.33) | MAP4K4HTR7SSTR2TDO2IDO2 | |
| SCHEMBL26529599 | 0.92 | GRM5 (0.34) | MAP4K4HTR7SSTR2TDO2IDO2 | |
| SCHEMBL26528772 | 0.91 | HTR7 (0.35) | MAP4K4HTR7SSTR2NTRK1NTRK3 | |
| SCHEMBL26528767 | 0.90 | NT5E (0.35) | MAP4K4HTR7SSTR2TDO2IDO2 | |
| SCHEMBL26529581 | 0.90 | MAP4K4 (0.33) | MAP4K4HTR7SSTR2NTRK1NTRK3 | |
| SCHEMBL26540818 | 0.90 | ICMT (0.37) | PGR | |
| SCHEMBL26529626 | 0.90 | ICMT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | MAP4K4 4467/4885HTR7 3455/4885SSTR2 4874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.